Racial disparities in melanoma survival - 15/10/16
Abstract |
Background |
Melanoma is a cutaneous malignancy common in the white population but can also occur in other racial groups.
Objective |
We sought to evaluate survival across racial groups in patients given a diagnosis of malignant melanoma.
Methods |
The Surveillance, Epidemiology, and End Results database was used to populate a cohort of 96,953 patients given a diagnosis of cutaneous melanoma as their primary cancer, from 1992 to 2009.
Results |
White patients had the longest survival time (P < .05), followed by Hispanic (P < .05), Asian American/Native American/Pacific Islander (P < .05), and black (P < .05) patients, respectively. Survival stratified by race and stage showed that for stages I and III, blacks had a significantly lower survival (P < .05), and increased hazard ratios (stage I hazard ratio, 3.037 [95% confidence interval, 2.335-3.951]; stage III hazard ratio, 1.864 [95% confidence interval, 1.211-2.87]). The proportion of later stage cutaneous melanoma (stages II-IV) was greater in blacks compared with whites.
Conclusion |
Despite higher incidence of cutaneous melanoma in whites, overall survival for cutaneous melanoma in non-whites was significantly lower. Our results suggest that more emphasis is needed for melanoma screening and awareness in non-white populations to improve survival outcomes.
Le texte complet de cet article est disponible en PDF.Key words : Asian American/Native American/Pacific Islander, black, epidemiology, health outcomes, melanoma, public health, race, stage, survival, white
Abbreviations used : AANAPI, CI, HR, NOS, RR, SEER
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 75 - N° 5
P. 983-991 - novembre 2016 Retour au numéro
Article précédent
- Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location
- Per Helsing, Trude Eid Robsahm, Linda Vos, Syed Mohammad Husain Rizvi, Lars Andreas Akslen, Marit Bragelien Veierød
- Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis
- Stanislav N. Tolkachjov, Roger H. Weenig, Nneka I. Comfere
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?